Cargando…

P932: PATIENT PERSPECTIVES ON BCMA-TARGETED THERAPIES FOR MULTIPLE MYELOMA: A SURVEY CONDUCTED IN A PATIENT ADVOCACY GROUP

Detalles Bibliográficos
Autores principales: Hydren, Jay R., Lin, Dee, Arturo Hurtado, Jorge, Sweeney, Nathan W., Wu, Bingcao, Gries, Katharine, Kim, Nina, Patel, Saurabh, Sborov, Douglas W., Berdeja, Jesus, Anderson, Larry D., Stephen Huo, Jinhai, Ahlstrom, Jennifer M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430948/
http://dx.doi.org/10.1097/01.HS9.0000970632.17730.f9
_version_ 1785091082099359744
author Hydren, Jay R.
Lin, Dee
Arturo Hurtado, Jorge
Sweeney, Nathan W.
Wu, Bingcao
Gries, Katharine
Kim, Nina
Patel, Saurabh
Sborov, Douglas W.
Berdeja, Jesus
Anderson, Larry D.
Stephen Huo, Jinhai
Ahlstrom, Jennifer M.
author_facet Hydren, Jay R.
Lin, Dee
Arturo Hurtado, Jorge
Sweeney, Nathan W.
Wu, Bingcao
Gries, Katharine
Kim, Nina
Patel, Saurabh
Sborov, Douglas W.
Berdeja, Jesus
Anderson, Larry D.
Stephen Huo, Jinhai
Ahlstrom, Jennifer M.
author_sort Hydren, Jay R.
collection PubMed
description
format Online
Article
Text
id pubmed-10430948
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104309482023-08-17 P932: PATIENT PERSPECTIVES ON BCMA-TARGETED THERAPIES FOR MULTIPLE MYELOMA: A SURVEY CONDUCTED IN A PATIENT ADVOCACY GROUP Hydren, Jay R. Lin, Dee Arturo Hurtado, Jorge Sweeney, Nathan W. Wu, Bingcao Gries, Katharine Kim, Nina Patel, Saurabh Sborov, Douglas W. Berdeja, Jesus Anderson, Larry D. Stephen Huo, Jinhai Ahlstrom, Jennifer M. Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430948/ http://dx.doi.org/10.1097/01.HS9.0000970632.17730.f9 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Hydren, Jay R.
Lin, Dee
Arturo Hurtado, Jorge
Sweeney, Nathan W.
Wu, Bingcao
Gries, Katharine
Kim, Nina
Patel, Saurabh
Sborov, Douglas W.
Berdeja, Jesus
Anderson, Larry D.
Stephen Huo, Jinhai
Ahlstrom, Jennifer M.
P932: PATIENT PERSPECTIVES ON BCMA-TARGETED THERAPIES FOR MULTIPLE MYELOMA: A SURVEY CONDUCTED IN A PATIENT ADVOCACY GROUP
title P932: PATIENT PERSPECTIVES ON BCMA-TARGETED THERAPIES FOR MULTIPLE MYELOMA: A SURVEY CONDUCTED IN A PATIENT ADVOCACY GROUP
title_full P932: PATIENT PERSPECTIVES ON BCMA-TARGETED THERAPIES FOR MULTIPLE MYELOMA: A SURVEY CONDUCTED IN A PATIENT ADVOCACY GROUP
title_fullStr P932: PATIENT PERSPECTIVES ON BCMA-TARGETED THERAPIES FOR MULTIPLE MYELOMA: A SURVEY CONDUCTED IN A PATIENT ADVOCACY GROUP
title_full_unstemmed P932: PATIENT PERSPECTIVES ON BCMA-TARGETED THERAPIES FOR MULTIPLE MYELOMA: A SURVEY CONDUCTED IN A PATIENT ADVOCACY GROUP
title_short P932: PATIENT PERSPECTIVES ON BCMA-TARGETED THERAPIES FOR MULTIPLE MYELOMA: A SURVEY CONDUCTED IN A PATIENT ADVOCACY GROUP
title_sort p932: patient perspectives on bcma-targeted therapies for multiple myeloma: a survey conducted in a patient advocacy group
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430948/
http://dx.doi.org/10.1097/01.HS9.0000970632.17730.f9
work_keys_str_mv AT hydrenjayr p932patientperspectivesonbcmatargetedtherapiesformultiplemyelomaasurveyconductedinapatientadvocacygroup
AT lindee p932patientperspectivesonbcmatargetedtherapiesformultiplemyelomaasurveyconductedinapatientadvocacygroup
AT arturohurtadojorge p932patientperspectivesonbcmatargetedtherapiesformultiplemyelomaasurveyconductedinapatientadvocacygroup
AT sweeneynathanw p932patientperspectivesonbcmatargetedtherapiesformultiplemyelomaasurveyconductedinapatientadvocacygroup
AT wubingcao p932patientperspectivesonbcmatargetedtherapiesformultiplemyelomaasurveyconductedinapatientadvocacygroup
AT grieskatharine p932patientperspectivesonbcmatargetedtherapiesformultiplemyelomaasurveyconductedinapatientadvocacygroup
AT kimnina p932patientperspectivesonbcmatargetedtherapiesformultiplemyelomaasurveyconductedinapatientadvocacygroup
AT patelsaurabh p932patientperspectivesonbcmatargetedtherapiesformultiplemyelomaasurveyconductedinapatientadvocacygroup
AT sborovdouglasw p932patientperspectivesonbcmatargetedtherapiesformultiplemyelomaasurveyconductedinapatientadvocacygroup
AT berdejajesus p932patientperspectivesonbcmatargetedtherapiesformultiplemyelomaasurveyconductedinapatientadvocacygroup
AT andersonlarryd p932patientperspectivesonbcmatargetedtherapiesformultiplemyelomaasurveyconductedinapatientadvocacygroup
AT stephenhuojinhai p932patientperspectivesonbcmatargetedtherapiesformultiplemyelomaasurveyconductedinapatientadvocacygroup
AT ahlstromjenniferm p932patientperspectivesonbcmatargetedtherapiesformultiplemyelomaasurveyconductedinapatientadvocacygroup